These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2819655)

  • 1. Development of leukemia after doxorubicin and cisplatin treatment for ovarian cancer.
    Chambers SK; Chopyk RL; Chambers JT; Schwartz PE; Duffy TP
    Cancer; 1989 Dec; 64(12):2459-61. PubMed ID: 2819655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary acute nonlymphocytic leukemia following successful chemotherapy combining cisplatin, doxorubicin, and cyclophosphamide for stage IV epithelial ovarian cancer.
    Yokoyama Y; Futagami M; Fukushi Y; Sakamoto T; Higuchi T; Fujii S; Sato S; Takami H; Saito Y
    Arch Gynecol Obstet; 2000 Apr; 263(4):206-7. PubMed ID: 10834334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preleukaemia presenting as sideroblastic anaemia after successful therapy of ovarian carcinoma.
    Planner RS; Taft LI; Cooper IA; Campbell JJ
    Aust N Z J Obstet Gynaecol; 1982 May; 22(2):116-7. PubMed ID: 6958249
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Comparison with results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agents.
    Pedersen-Bjergaard J; Ersbøll J; Sørensen HM; Keiding N; Larsen SO; Philip P; Larsen MS; Schultz H; Nissen NI
    Ann Intern Med; 1985 Aug; 103(2):195-200. PubMed ID: 4014901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian cancer. Effective treatment after alkylating-agent failure.
    Vogl SE; Greenwald E; Kaplan BH; Moukhtar M; Wollner D
    JAMA; 1979 May; 241(18):1908-11. PubMed ID: 107337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical trial of cisplatin in the treatment of ovarian carcinoma].
    Yoshizawa H; Kanazawa K; Takeuchi S; Okamura Y; Goto S; Kajiwara T
    Gan To Kagaku Ryoho; 1982 May; 9(5):822-30. PubMed ID: 6764112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvage intraperitoneal therapy of ovarian cancer employing cisplatin and etoposide: a Gynecologic Oncology Group study.
    Markman M; Blessing JA; Major F; Manetta A
    Gynecol Oncol; 1993 Aug; 50(2):191-5. PubMed ID: 8375734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukemia following cisplatin-based chemotherapy for ovarian carcinoma at Roswell Park.
    Sprance HE; Hempling RE; Piver MS
    Eur J Gynaecol Oncol; 1992; 13(2):131-7. PubMed ID: 1587290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute myeloblastic leukemia after cure of ovarian cancer.
    Greenspan EM; Tung BG
    JAMA; 1974 Oct; 230(3):418-20. PubMed ID: 4212912
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute leukemia following cisplatin-based chemotherapy in a patient with ovarian cancer.
    Reed E; Evans MK
    J Natl Cancer Inst; 1990 Mar; 82(5):431-2. PubMed ID: 2304092
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute nonlymphocytic leukemia following treatment of testicular cancer and gastric cancer with combination chemotherapy not including alkylating agents: report of two cases.
    Pedersen-Bjergaard J; Rørth M; Avnstrøm S; Philip P; Hou-Jensen K
    Am J Hematol; 1985 Apr; 18(4):425-9. PubMed ID: 2983538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 4'-epi-doxorubicin in combination with cisplatin in advanced ovarian cancer.
    Martoni A; Tomasi L; Farabegoli G; Fruet F; Pannuti F
    Cancer Treat Rep; 1984 Nov; 68(11):1391-3. PubMed ID: 6594196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy in advanced ovarian cancer.
    Schein PS
    Geriatrics; 1973 Dec; 28(12):89-95. PubMed ID: 4128004
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute leukemia in a patient with ovarian cancer treated with cisplatin-based chemotherapy and alkeran.
    Markman M; Hoskins WB
    Cancer Invest; 1990; 8(1):113-4. PubMed ID: 2350715
    [No Abstract]   [Full Text] [Related]  

  • 15. Six-drug chemotherapy (hexamethylmelamine, doxorubicin, cisplatin, cyclophosphamide, methotrexate, and 5-FU; CHAMP-5) for ovarian carcinoma: alternating sequences of combination regimens.
    Pasmantier MW; Coleman M; Silver RT; Ballard WP
    Cancer Treat Rep; 1985 Jun; 69(6):689-93. PubMed ID: 3926310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series.
    Pedersen-Bjergaard J; Philip P; Larsen SO; Andersson M; Daugaard G; Ersbøll J; Hansen SW; Hou-Jensen K; Nielsen D; Sigsgaard TC
    Leukemia; 1993 Dec; 7(12):1975-86. PubMed ID: 8255096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin (CHAD) as second-line chemotherapy for ovarian adenocarcinoma.
    Piver MS; Lele S; Barlow JJ
    Cancer Treat Rep; 1981; 65(1-2):149-51. PubMed ID: 6784921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute nonlymphocytic leukemia after therapy with alkylating agents for ovarian cancer: a study of five randomized clinical trials.
    Greene MH; Boice JD; Greer BE; Blessing JA; Dembo AJ
    N Engl J Med; 1982 Dec; 307(23):1416-21. PubMed ID: 6752720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute monocytic or myelomonocytic leukemia with balanced chromosome translocations to band 11q23 after therapy with 4-epi-doxorubicin and cisplatin or cyclophosphamide for breast cancer.
    Pedersen-Bjergaard J; Sigsgaard TC; Nielsen D; Gjedde SB; Philip P; Hansen M; Larsen SO; Rørth M; Mouridsen H; Dombernowsky P
    J Clin Oncol; 1992 Sep; 10(9):1444-51. PubMed ID: 1517787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian carcinoma terminating in acute nonlymphocytic leukemia following alkylating agent therapy.
    Kapadia SB; Krause JR
    Cancer; 1978 May; 41(5):1676-9. PubMed ID: 417794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.